As the senior policy advisor, Hannah Frye focuses on health and biomedical research policy, working with such agencies as the National Institutes of Health, the Advanced Research Projects Agency for Health and the Food and Drug Administration and their related Congressional committees.

Hannah Frye joined the MIT Washington Office in November 2022 after serving as a science fellow with the California Council on Science & Technology on the California Senate Committee on Business, Professions, and Economic Development. 

Hannah received her Ph.D. in neuroscience at Washington University in St. Louis, and her B.S. in chemistry with a biochemistry emphasis and a minor in biological sciences from Missouri University of Science and Technology. Her doctoral work focused on dissecting the interplay of genetics and biological sex on memory and opioid use disorder risk. Hannah has served as a guest editor with the Journal of Science Policy and Governance, as an early career policy ambassador with the Society for Neuroscience and as the policy and advocacy chair for the graduate student science policy group ProSPER at Washington University.